September 21, 2026

Siti Muinah

Redefining Neurosurgery: How Minimally Invasive Laser Therapy is Extending Lives in the Fight Against Glioblastoma redefining-neurosurgery-how-minimally-invasive-laser-therapy-is-extending-lives-in-the-fight-against-glioblastoma

Redefining Neurosurgery: How Minimally Invasive Laser Therapy is Extending Lives in the Fight Against Glioblastoma

Siti Muinah August 27, 2026
For decades, a diagnosis of glioblastoma—the most aggressive and formidable form of primary brain cancer—has been synonymous...
Read More Read more about Redefining Neurosurgery: How Minimally Invasive Laser Therapy is Extending Lives in the Fight Against Glioblastoma
AI Breakthrough: UCLA Study Reveals Artificial Intelligence Could Revolutionize Early Detection of Interval Breast Cancers ai-breakthrough-ucla-study-reveals-artificial-intelligence-could-revolutionize-early-detection-of-interval-breast-cancers

AI Breakthrough: UCLA Study Reveals Artificial Intelligence Could Revolutionize Early Detection of Interval Breast Cancers

Siti Muinah August 26, 2026
LOS ANGELES, CA – A groundbreaking new study spearheaded by investigators at the UCLA Health Jonsson Comprehensive...
Read More Read more about AI Breakthrough: UCLA Study Reveals Artificial Intelligence Could Revolutionize Early Detection of Interval Breast Cancers
The Frontier of Genetic Medicine: Understanding the Divide Between In Vivo and Ex Vivo Therapies the-frontier-of-genetic-medicine-understanding-the-divide-between-in-vivo-and-ex-vivo-therapies

The Frontier of Genetic Medicine: Understanding the Divide Between In Vivo and Ex Vivo Therapies

Siti Muinah August 25, 2026
The landscape of modern medicine is currently undergoing a paradigm shift. For decades, the therapeutic arsenal against...
Read More Read more about The Frontier of Genetic Medicine: Understanding the Divide Between In Vivo and Ex Vivo Therapies
The Wild West of Weight Loss: FDA Flags Surge in Adverse Events Linked to Compounded GLP-1s the-wild-west-of-weight-loss-fda-flags-surge-in-adverse-events-linked-to-compounded-glp-1s

The Wild West of Weight Loss: FDA Flags Surge in Adverse Events Linked to Compounded GLP-1s

Siti Muinah August 25, 2026
The meteoric rise of GLP-1 receptor agonists—the blockbuster class of drugs including semaglutide and tirzepatide—has fundamentally altered...
Read More Read more about The Wild West of Weight Loss: FDA Flags Surge in Adverse Events Linked to Compounded GLP-1s
Advancing the Frontier of Metastatic Breast Cancer Research: A Report on Advocacy, Innovation, and the Evolving Regulatory Landscape advancing-the-frontier-of-metastatic-breast-cancer-research-a-report-on-advocacy-innovation-and-the-evolving-regulatory-landscape

Advancing the Frontier of Metastatic Breast Cancer Research: A Report on Advocacy, Innovation, and the Evolving Regulatory Landscape

Siti Muinah August 23, 2026
Introduction In the volatile landscape of oncology, where scientific breakthroughs often collide with the harsh realities of...
Read More Read more about Advancing the Frontier of Metastatic Breast Cancer Research: A Report on Advocacy, Innovation, and the Evolving Regulatory Landscape

You may have missed

a-new-titan-in-oncology-telixs-1-65-billion-acquisition-of-itm-reshapes-the-radiopharmaceutical-landscape

A New Titan in Oncology: Telix’s $1.65 Billion Acquisition of ITM Reshapes the Radiopharmaceutical Landscape

Laily UPN September 21, 2026
a-new-era-of-health-sovereignty-who-and-african-union-forge-strategic-alliance-to-redefine-continental-wellness

A New Era of Health Sovereignty: WHO and African Union Forge Strategic Alliance to Redefine Continental Wellness

Nana Muazin September 21, 2026
a-historic-victory-timor-leste-achieves-malaria-free-certification

A Historic Victory: Timor-Leste Achieves Malaria-Free Certification

Nana September 21, 2026
a-new-era-for-genomic-science-ashg-announces-strategic-publishing-partnership-with-oxford-university-press-1

A New Era for Genomic Science: ASHG Announces Strategic Publishing Partnership with Oxford University Press

Ali Ikhwan September 21, 2026